Imbruvica (ibrutinib) is an oral cancer medication used for certain leukemias, blood cancers, and blood cell conditions. It commonly causes diarrhea, tiredness, and easy bruising.
Imbruvica (ibrutinib) is a kinase inhibitor. It blocks a protein in your body to help stop cancer cells from growing and multiplying.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Imbruvica (ibrutinib) can be taken for many years. Continue to take this medication until your provider tells you to stop. Most people will continue to take Imbruvica (ibrutinib) until the side effects become too severe or their condition worsens.
Don't stop Imbruvica (ibrutinib), unless your provider has instructed you to do so. Stopping the medication early or taking a break from the medication can cause disease flare ups and can cause your condition to worsen. If you have a surgery scheduled, your provider might tell you to stop taking the medication a few days before and after your procedure due to the higher risk of bleeding. Your provider will monitor you closely in this situation.
It's best to avoid alcohol while taking Imbruvica (ibrutinib). This can help with diarrhea that you might experience during treatment. In addition, alcohol can damage the liver, which helps break down the medication in your body. Liver damage can raise medication levels in your body and raise your risk of side effects. This is also why people with severe liver problems should avoid Imbruvica (ibrutinib).
No, Imbruvica (ibrutinib) shouldn't be used in pregnancy, as it can harm an unborn baby. If you're female of childbearing age, you'll need to take a pregnancy test before you start Imbruvica (ibrutinib) to make sure you're not pregnant. In addition, whether you're a female or male taking Imbruvica (ibrutinib), if you or your partner is able to become pregnant, use reliable birth control during treatment and for 1 month after stopping the medication. Your partner can also use birth control during this time to prevent pregnancy as well.
Imbruvica (ibrutinib) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Imbruvica (ibrutinib) can cause many different bleeding-related side effects that can be serious. Bruising and red spots on the skin are most common, but serious brain and stomach bleeds have also been reported. The risk of major bleeding is higher if you're also taking antiplatelet medications or blood thinners. The risk for a serious bleed after surgery is also higher, so let your provider know if you have a procedure scheduled. They might tell you to stop your medication for a few days before and after your surgery. Contact your provider or get medical help right away if you experience blood in your vomit, urine, or stool, or a sudden and severe headache.
Some people taking Imbruvica (ibrutinib) have had serious, and sometimes fatal, infections. Wash your hands well with soap and warm water often to protect yourself from infections. Make sure to report any signs of an illness, especially fever and chills. If your risk for an infection is high, your provider might prescribe preventative medication.
Rarely, serious heart conditions, like abnormal heart rhythms and heart failure, have occurred in some people taking Imbruvica (ibrutinib). Make sure your provider knows your full medical history. They might monitor you more closely if you have a history of heart conditions or have ever had an irregular heart beat. Contact your provider right away if you ever faint, or have a fast heart beat, lightheadedness, chest pain, or sudden shortness of breath.
About 20% of people in clinical studies taking Imbruvica (ibrutinib) had high blood pressure. Make sure you go to your regularly scheduled clinic visits so your provider can monitor your blood pressure. If your blood pressure starts to rise, your provider can prescribe blood pressure-lowering medications for you.
Sometimes, Imbruvica (ibrutinib) can raise your risk for developing other cancers. The most common type of cancer was non-melanoma skin cancer. Wear protective clothing and sunscreen if you're going to be under direct sunlight.
Rarely, Imbruvica (ibrutinib) causes tumor lysis syndrome, a condition that can be dangerous if not treated right away. This is more likely if you have a lot of cancerous cells (high tumor burden), are dehydrated, or have kidney damage. Talk to your provider right away if you experience dark urine, a racing heart, muscle cramps or spasms, numbness, nausea, or vomiting within the first week of taking Imbruvica (ibrutinib). You'll need to get appropriate care to prevent complications.
The typical dose is 420 mg by mouth once daily.
Your dose might differ if you have liver problems or are also taking certain medications that can interact with Imbruvica (ibrutinib).